drugset
drugset / Trial / NCT04030247

Impact of Plant Sterol Supplement on LDL-C Lowering in Low-to-Moderate Risk South Asian Patients

NCT04030247 ↗

Phase 4 Completed 50 enrolled Stanford University Piper Biosciences, Inc. · collab
NaSingle-groupOpen-labelTreatment

Summary

The purpose of this study is to measure the incremental effectiveness of a twice daily plant sterol supplement in a population of South Asian patients who have low-to-moderate cardiovascular disease (CVD) risk.

Timeline

Start
2020-01-06
Primary completion
2021-03-31
Completion
2021-03-31

Drugs

EvaluationDrugModalityDoseRoute
Subject Plant Sterol Unknown — —

Indications

No indication recorded.